Early aggressive therapy for patients with juvenile idiopathic arthritis: are we there yet?

J Rheumatol. 2014 Dec;41(12):2343-6. doi: 10.3899/jrheum.141051.

Authors

Roberta A Berard¹, Ronald M Laxer²

Affiliations

¹ Pediatric Rheumatologist, Children's Hospital, London Health Sciences Centre; Assistant Professor of Pediatrics, Western University;
² Professor of Pediatrics and Medicine, University of Toronto, Staff Rheumatologist, The Hospital for Sick Children, Toronto, Ontario, Canada. [email protected].

PMID: 25452178
DOI: 10.3899/jrheum.141051

No abstract available

Publication types

Editorial
Comment

MeSH terms

Arthritis, Juvenile / diagnosis*
Arthritis, Juvenile / drug therapy*
Disability Evaluation*
Humans
Immunoglobulin G / therapeutic use*
Methotrexate / therapeutic use*
Prednisolone / therapeutic use*
Receptors, Tumor Necrosis Factor / therapeutic use*

Substances

Immunoglobulin G
Receptors, Tumor Necrosis Factor
Prednisolone
Methotrexate